4.6 Review

Soluble Ligands and Their Receptors in Human Embryo Development and Implantation

Journal

ENDOCRINE REVIEWS
Volume 36, Issue 1, Pages 92-130

Publisher

ENDOCRINE SOC
DOI: 10.1210/er.2014-1046

Keywords

-

Funding

  1. Vitrolife AB
  2. Spanish Ministry for Economy and Competitiveness (Miguel Servet Grant) [CP13/00075]
  3. Spanish Ministry for Economy and Competitiveness via Instituto de Salud Carlos III (Miguel Servet Grant) [CP13/00038]
  4. Merck Serono
  5. Ferring Pharmaceuticals
  6. Merck Sharpe Dohme
  7. OvaScience LLC
  8. Pantharei Bioscience
  9. Schering AG

Ask authors/readers for more resources

Extensive evidence suggests that soluble ligands and their receptors mediate human preimplantation embryo development and implantation. Progress in this complex area has been ongoing since the 1980s, with an ever-increasing list of candidates. This article specifically reviews evidence of soluble ligands and their receptors in the human preimplantation stage embryo and female reproductive tract. The focus will be on candidates produced by the human preimplantation embryo and those eliciting developmental responses in vitro, as well as endometrial factors related to implantation and receptivity. Pathways to clinical translation, including innovative diagnostics and other technologies, are also highlighted, drawing from this collective evidence toward facilitating joint improvements in embryo quality and endometrial receptivity. This strategy could not only benefit clinical outcomes in reproductive medicine but also provide broader insights into the peri-implantation period of human development to improve fetal and neonatal health.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available